John J. Crowley - 01 Jul 2024 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Financial Officer
Signature
/s/ Gregory Weinhoff, attorney-in-fact
Issuer symbol
CNTA
Transactions as of
01 Jul 2024
Net transactions value
$0
Form type
4
Filing time
02 Jul 2024, 16:30:32 UTC
Previous filing
17 Jun 2024
Next filing
04 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTA Share Option (right to buy) Award $0 +600,000 $0.000000 600,000 01 Jul 2024 Ordinary Shares 600,000 $8.80 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to such option shall vest and become exercisable on July 1, 2025 and the remaining 75% of the shares subject to such option shall vest and become exercisable in 36 monthly installments on the first day of each month thereafter.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Remarks:

Exhibit 24 - Power of Attorney